Anthony Duncan, an American content creator who survived ‘AI psychosis’, has candidly opened up about the very first signs something was wrong.

Reviva Pharmaceuticals' brilaroxazine shows promise for schizophrenia, but regulatory and financial risks persist. Read why ...

A research team led by Dr Brian Chung Hon-yin (third left) has revealed that individuals who experienced childhood maltreatment face markedly elevated ...

A witness with schizophrenia was the reason a prosecutor allowed a man to plead guilty to manslaughter and get only six years ...

Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a ...

Many people live with a secret that feels almost impossible to describe. They hear speech or whispers that nobody else detects. These are not vague impressions. They can feel as solid as a friend ...

This post was co-authored by Shontae Cameron, and Robert T. Muller, Ph.D. The World Health Organization estimates that schizophrenia affects around 24 million people, or roughly 1 in 300 individuals ...

Scientists have discovered a surprising benefit of the acne drug doxycycline: it may lower the risk of schizophrenia. Teens prescribed the antibiotic were about one-third less likely to develop the ...

A commonly prescribed antibiotic could help reduce the risk of some young people developing schizophrenia, new research published in the American Journal of Psychiatry suggests. Experts found that ...

Nanobodies—tiny proteins derived from animals in the camelid family including camels, llamas, and alpacas—could be useful in treating brain disorders like schizophrenia and Alzheimer's disease. In a ...